Empowered Funds LLC Purchases Shares of 19,147 CorVel Corp. $CRVL

Empowered Funds LLC purchased a new position in shares of CorVel Corp. (NASDAQ:CRVL) in the second quarter, according to its most recent filing with the SEC. The firm purchased 19,147 shares of the business services provider’s stock, valued at approximately $1,197,000.

Several other hedge funds have also recently made changes to their positions in CRVL. Northwestern Mutual Wealth Management Co. bought a new stake in shares of CorVel during the 3rd quarter valued at about $31,000. Los Angeles Capital Management LLC bought a new stake in CorVel in the fourth quarter worth approximately $33,000. Quarry LP lifted its stake in CorVel by 218.6% in the third quarter. Quarry LP now owns 513 shares of the business services provider’s stock valued at $40,000 after buying an additional 352 shares during the period. Rockefeller Capital Management L.P. grew its position in shares of CorVel by 66.9% during the 4th quarter. Rockefeller Capital Management L.P. now owns 574 shares of the business services provider’s stock worth $39,000 after buying an additional 230 shares during the period. Finally, Versant Capital Management Inc grew its position in shares of CorVel by 59.7% during the 2nd quarter. Versant Capital Management Inc now owns 907 shares of the business services provider’s stock worth $57,000 after buying an additional 339 shares during the period. 51.36% of the stock is owned by institutional investors.

Insider Transactions at CorVel

In other news, VP Jennifer Yoss sold 2,100 shares of the stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $70.92, for a total transaction of $148,932.00. Following the completion of the transaction, the vice president owned 2,173 shares in the company, valued at approximately $154,109.16. This represents a 49.15% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jeffrey J. Michael sold 9,000 shares of CorVel stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $60.98, for a total value of $548,820.00. Following the completion of the sale, the director directly owned 559,721 shares of the company’s stock, valued at approximately $34,131,786.58. This trade represents a 1.58% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 20,197 shares of company stock worth $1,315,568 in the last ninety days. Company insiders own 39.72% of the company’s stock.

CorVel Price Performance

Shares of CRVL stock opened at $68.23 on Friday. The company has a market cap of $3.48 billion, a P/E ratio of 30.32 and a beta of 0.97. CorVel Corp. has a one year low of $44.83 and a one year high of $93.45. The firm has a 50-day moving average of $64.25 and a 200-day moving average of $58.99.

CorVel (NASDAQ:CRVL) last posted its quarterly earnings data on Tuesday, August 4th. The business services provider reported $0.63 earnings per share for the quarter. The business had revenue of $259.93 million for the quarter. CorVel had a return on equity of 29.92% and a net margin of 11.72%.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on CRVL shares. Wall Street Zen raised shares of CorVel from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Weiss Ratings raised shares of CorVel from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday. One analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company has an average rating of “Hold”.

About CorVel

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).